Sunda Biotech announced that 17.8407 million restricted shares issued by the company to specific targets will be listed and circulated on December 25, 2025, accounting for 9.44% of the company's total share capital. On June 25, 2025, the total share capital was changed from 171,188,958 shares to 189,029,624 shares after the company completed registration for issuing A-shares to specific targets. Shareholders of the restricted shares have all promised that the subscribed shares will not be transferred within 6 months from the date the issuance ends. As of the date of disclosure of the announcement, the shareholders have strictly fulfilled their promises. The sponsor agency has no objection to the circulation of this restricted stock listing.

Sunda Biotech announced that 17.8407 million restricted shares issued by the company to specific targets will be listed and circulated on December 25, 2025, accounting for 9.44% of the company's total share capital. On June 25, 2025, the total share capital was changed from 171,188,958 shares to 189,029,624 shares after the company completed registration for issuing A-shares to specific targets. Shareholders of the restricted shares have all promised that the subscribed shares will not be transferred within 6 months from the date the issuance ends. As of the date of disclosure of the announcement, the shareholders have strictly fulfilled their promises. The sponsor agency has no objection to the circulation of this restricted stock listing.